基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.
Tumor infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in relation to pathological complete remission to neoadjuvant therapy and prognosis in triple negative breast cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
NLR 可能有助于筛查新辅助治疗后 TNBC 患者的高危人群。
探讨新辅助治疗(NAT)前外周血中性粒细胞与淋巴细胞比值(NLR)及TIL(肿瘤浸润淋巴细胞)与三阴性乳腺癌患者预后之间的相关性。
共筛选出126例接受NAT的TNBC患者。治疗前通过免疫组化检测空心针穿刺活检标本中的TILs、CD8+TIL和FOXP3+TIL,并计算NLR。采用Kaplan-Meier分析估计生存率。使用Cox比例风险回归进行单因素和多因素分析。
NLR与TILs密度呈负相关(p = 0.040),FOXP3+ TIL与NLR呈正相关(p = 0.019)。低NLR/高TILs密度的患者显示出最高的pCR率(46/48,95%),而高NLR/低TILs密度的患者中仅有6/22(21%)达到pCR。多因素分析显示,高NLR与pCR独立相关(HR = 5.043,95%CI = 1.637-15.535,p = 0.005)。高T分期、淋巴结受累、淋巴血管侵犯、高NLR、低TILs密度和低CD8+ TIL与较差的OS和BCSS相关。多因素Cox回归分析显示,高NLR(HR = 36.182,95%CI = 4.120-317.759,p = 0.001)、高CD8+ TIL密度(HR = 0.182,95%CI = 0.044-0.754,p = 0.019)与较差的OS独立相关。同样,高NLR(HR = 23.989,95%CI = 2.275-252.131,p = 0.008)与较差的BCSS独立相关。
To explore the correlation between the peripheral blood neutrophil-to-lymphocyte ratio (NLR) and tumor infiltrating lymphocyte (TIL) before neoadjuvant therapy (NAT) and the prognosis of patients with triple negative breast cancer. METHOD: A total of 126 patients with TNBC who received NAT were screened out. TILs, CD8+TIL and FOXP3+TIL were detected by immunohistochemistry in core needle biopsy specimens before treatment, and NLR was calculated. Kaplan-Meier analysis was used to estimate survival rates. Univariate and multivariate analyses were performed using Cox proportional hazards regression.
NLR was negatively correlated with TILs density (p = 0.040) and FOXP3+ TIL was positively correlated with NLR (p = 0.019). Patients with low NLR/high TILs density showed the highest pCR rate (46/48, 95 %), while only 6/22 patients (21 %) with high NLR/low TILs density achieved pCR. Multivariate analysis showed that high NLR was independently associated with pCR ((HR = 5.043, 95 %CI = 1.637-15.535, p = 0.005). High T stage, lymph node involvement, lymphovascular invasion, high NLR, low TILs density and low CD8+ TIL were associated with poor OS and BCSS. Multivariate Cox regression analysis showed that high NLR (HR = 36.182, 95 %CI = 4.120-317.759, p = 0.001), high CD8+ TIL density (HR = 0.182, 95 %CI = 0.044-0.754, p = 0.019) were independently associated with poor OS. Similarly, high NLR (HR = 23.989, 95 %CI = 2.275-252.131, p = 0.008) was independently associated with worse BCSS.
NLR may help to screen the high-risk population of TNBC patients after neoadjuvant therapy.
MEMBER ACCOUNT
登录成功会直接打开下一页。